Advisor Group Holdings, Inc. Biomea Fusion, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 8,667 shares of BMEA stock, worth $12,047. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,667
Previous 3,857
124.71%
Holding current value
$12,047
Previous $14,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMEA
# of Institutions
109Shares Held
16.1MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$4.96 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.26 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$1.92 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.11 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$870,0740.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $40.7M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...